Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Ascenta Capital
Biotech
Inside Incubate’s battles for biotech on Capitol Hill
John Stanford is making the case that the success of the domestic biotech industry is an issue of national security and economic competitiveness.
Will Maddox
Mar 27, 2026 8:00am
Triana crafts $120M series B to take glue degrader into clinic
Dec 3, 2025 10:35am
Tubulis touts $361M series C as next-gen ADC data drop nears
Oct 15, 2025 5:01am
2 ex-Moderna leaders unveil $325M inaugural VC fund
Oct 9, 2025 3:09pm
